Annexin Pharmaceuticals Balance Sheet Health
Financial Health criteria checks 4/6
Annexin Pharmaceuticals has a total shareholder equity of SEK36.0M and total debt of SEK0.0, which brings its debt-to-equity ratio to 0%. Its total assets and total liabilities are SEK41.4M and SEK5.4M respectively.
Key information
0%
Debt to equity ratio
SEK 0
Debt
Interest coverage ratio | n/a |
Cash | SEK 37.35m |
Equity | SEK 36.04m |
Total liabilities | SEK 5.37m |
Total assets | SEK 41.41m |
Recent financial health updates
Financial Position Analysis
Short Term Liabilities: ANNX's short term assets (SEK39.7M) exceed its short term liabilities (SEK5.4M).
Long Term Liabilities: ANNX has no long term liabilities.
Debt to Equity History and Analysis
Debt Level: ANNX is debt free.
Reducing Debt: ANNX has no debt compared to 5 years ago when its debt to equity ratio was 1.3%.
Balance Sheet
Cash Runway Analysis
For companies that have on average been loss-making in the past, we assess whether they have at least 1 year of cash runway.
Stable Cash Runway: ANNX has less than a year of cash runway based on its current free cash flow.
Forecast Cash Runway: ANNX has less than a year of cash runway if free cash flow continues to reduce at historical rates of 9% each year